Kalpathy-Cramer, Jayashree, Vyshak Chandra, Xiao Da, Yangming Ou, Kyrre Emblem, Alona Muzikansky, Xuezhu Cai, et al. 2017. “Phase II Study of Tivozanib, an Oral VEGFR Inhibitor, in Patients With Recurrent Glioblastoma”. Journal of Neuro-Oncology 131 (3): 603–610.